| Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy F Yang, Y Qin, J Lv, Y Wang, H Che, X Chen, Y Jiang, A Li, X Sun, E Yue, ... Cell death & disease 9 (10), 1000, 2018 | 232 | 2018 |
| Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma E Yue, G Tuguzbaeva, X Chen, Y Qin, A Li, X Sun, C Dong, Y Liu, Y Yu, ... Phytomedicine 56, 286-294, 2019 | 102 | 2019 |
| A novel circular RNA mediates pyroptosis of diabetic cardiomyopathy by functioning as a competing endogenous RNA F Yang, A Li, Y Qin, H Che, Y Wang, J Lv, Y Li, H Li, E Yue, X Ding, Y Yu, ... Molecular Therapy-Nucleic Acids 17, 636-643, 2019 | 99 | 2019 |
| Downregulation of long non-coding RNA Kcnq1ot1: an important mechanism of arsenic trioxide-induced long QT syndrome Y Jiang, W Du, Q Chu, Y Qin, G Tuguzbaeva, H Wang, A Li, G Li, Y Li, ... Cellular Physiology and Biochemistry 45 (1), 192-202, 2018 | 58 | 2018 |
| MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway A Li, Y Yu, X Ding, Y Qin, Y Jiang, X Wang, G Liu, X Chen, E Yue, XI Sun, ... International Journal of Cardiology 307, 137-145, 2020 | 46 | 2020 |
| Overexpression of miR-135b attenuates pathological cardiac hypertrophy by targeting CACNA1C Q Chu, A Li, X Chen, Y Qin, X Sun, Y Li, E Yue, C Wang, X Ding, Y Yan, ... International journal of cardiology 269, 235-241, 2018 | 36 | 2018 |
| Caspase-1 regulates Ang II-induced cardiomyocyte hypertrophy via up-regulation of IL-1β Y Bai, X Sun, Q Chu, A Li, Y Qin, Y Li, E Yue, H Wang, GY Li, SM Zahra, ... Bioscience reports 38 (2), BSR20171438, 2018 | 32 | 2018 |
| Anthocyanin protects cardiac function and cardiac fibroblasts from high-glucose induced inflammation and myocardial fibrosis by inhibiting IL-17 E Yue, Y Yu, X Wang, B Liu, Y Bai, B Yang Frontiers in Pharmacology 11, 593633, 2021 | 22 | 2021 |
| PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting αv integrin/FAK/Src signaling in oral squamous cell carcinoma cells G Tuguzbaeva, E Yue, X Chen, L He, X Li, J Ju, Y Qin, V Pavlov, Y Lu, ... Acta Pharmaceutica Sinica B 9 (6), 1163-1173, 2019 | 22 | 2019 |
| Anthocyanidin attenuates myocardial ischemia induced injury via inhibition of ROS‐JNK‐Bcl‐2 pathway: New mechanism of anthocyanidin action MZ Syeda, MB Fasae, E Yue, AP Ishimwe, Y Jiang, Z Du, B Yang, Y Bai Phytotherapy Research 33 (12), 3129-3139, 2019 | 18 | 2019 |
| Targeting CA-125 transcription by development of a conditionally replicative adenovirus for ovarian cancer treatment E Yue, G Yang, Y Yao, G Wang, A Mohanty, F Fan, L Zhao, Y Zhang, ... Cancers 13 (17), 4265, 2021 | 9 | 2021 |
| Repositioning quinacrine toward treatment of ovarian cancer by rational combination with TRAIL R Liang, Y Yao, G Wang, E Yue, G Yang, X Qi, Y Wang, L Zhao, T Zheng, ... Frontiers in oncology 10, 1118, 2020 | 7 | 2020 |
| Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment. Cancers 2021, 13, 4265 E Yue, G Yang, Y Yao, G Wang, A Mohanty, F Fan, L Zhao, Y Zhang, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Regression of ovarian cancer xenografts by depleting or inhibiting RLIP SK Ramisetty, P Garg, A Mohanty, T Mirzapoiazova, E Yue, E Wang, ... Biochemical Pharmacology 217, 115847, 2023 | | 2023 |
| Targeting mercapturic acid pathway transporter in chemoradiotherapy resistant ovarian cancer SS Singhal, E Yue, P Kulkarni, D Horne, S Awasthi, E Wang, R Salgia Cancer Research 83 (7_Supplement), 1699-1699, 2023 | | 2023 |
| Genetic modification of mesothelial cells with full length membrane-bound TRAIL for ovarian cancer treatment E Yue, T Walser, T Mirzapoiazova, R Salgia, EW Wang Cancer Research 83 (7_Supplement), 2739-2739, 2023 | | 2023 |
